Provided by Tiger Trade Technology Pte. Ltd.

MaxCyte Inc

0.7569
-0.0083-1.08%
Post-market: 0.7426-0.0143-1.89%16:34 EDT
Volume:833.48K
Turnover:628.97K
Market Cap:80.74M
PE:-1.76
High:0.8000
Open:0.7700
Low:0.7408
Close:0.7652
52wk High:3.17
52wk Low:0.6434
Shares:106.67M
Float Shares:96.17M
Volume Ratio:1.09
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4299
EPS(LYR):-0.3916
ROE:-23.19%
ROA:-13.66%
PB:0.45
PE(LYR):-1.93

Loading ...

Top News Today/Canada: Bank of Canada to Lose Two Members of Rate-Setting Governing Council

Dow Jones
·
20 mins ago

BRIEF-Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer

Reuters
·
Yesterday

MaxCyte Inc - Parmeet Ahuja Succeeds Douglas Swirsky as CFO

THOMSON REUTERS
·
Yesterday

Press Release: MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer

Dow Jones
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

MaxCyte Faces Nasdaq Noncompliance Over Minimum Bid Price

TIPRANKS
·
Mar 21

Nasdaq warns MaxCyte of listing-rule breach after 30-day sub-$1 bid price streak

Reuters
·
Mar 21

MaxCyte Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
Mar 21

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 18

MaxCyte announced the launch of ExPERT DTx

TIPRANKS
·
Feb 24

MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery

GlobeNewswire
·
Feb 24

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

GlobeNewswire
·
Feb 24

MaxCyte Expects Core Revenue of Up to $29.6 Million for 2025

Reuters
·
Jan 13

MaxCyte sees Q4 core revenue $6.6M-$6.7M, consensus $9.3M

TIPRANKS
·
Jan 12

BRIEF-Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results

Reuters
·
Jan 12

MaxCyte Inc - Q4 Core Revenue Expected Between $6.6 Mln and $6.7 Mln

THOMSON REUTERS
·
Jan 12

Press Release: MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Jan 12

MaxCyte Announces Planned CFO Transition In 2026

Reuters
·
Nov 20, 2025

MaxCyte Q3 Revenue USD 6.4 Million Vs. IBES Estimate USD 8.37 Million

Reuters
·
Nov 20, 2025